No Data
Express News | Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Express News | Expion360 Inc. Announces $2.6 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
Express News | LiveOne (Nasdaq: Lvo) Subsidiary Splitmind Hits # 1 on Billboard With Sza, Expected to Drive Significant Revenue
Innoviz Regains Compliance With Nasdaq's Minimum Bid Price Requirement
Express News | Hope Therapeutics, Inc. and NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for Its International Network of Interventional Psychiatry Clinics
Nasdaq's (NASDAQ:NDAQ) Investors Will Be Pleased With Their Stellar 132% Return Over the Last Five Years